Subcutaneously administered low molecular weight heparin for anticoagulation in patients undergoing lung transplantation with periprocedural ECMO support - a retrospective, observational cohort study.

• Conditions: lung transplantationextracorporeal membrane oxygenation; Z94.2; Lung transplant status

• Registration Number: DRKS00013593
• Lead Sponsor: Medizinische Universität WienUniversitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-12-12
• Study Completion: 2018-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 102

Inclusion Criteria

lung transplantation
- between 01/01/2006 and 04/30/2017
- perioperative ECMO support
- anticoagulation with UFH or LMWH
- acceptable data consistency

Exclusion Criteria

none

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The history of included patients will be screende for severe bleeding events (surgical intervention for bleeding control, intracranial bleeding, uncontrollable bleeding).

Secondary Outcome Measures

Name	Time	Method
The history of included patients will be screened for thromboembolic events (arterial thromboembolic events, including myocardial infarction and stroke, venous thromboembolism including pulmonary embolism and extracorporeal thrombosis).